A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein.
ZEBRA is a site-specific DNA binding protein that functions as a transcriptional activator and as an origin binding protein. Both activities require that ZEBRA recognizes DNA motifs that are scattered along the viral genome. The mechanism by which ZEBRA discriminates between the origin of lytic replication and promoters of EBV early genes is not well understood. We explored the hypothesis that activation of replication requires stronger association between ZEBRA and DNA than does transcription. A ZEBRA mutant, Z(S173A), at a phosphorylation site and three point mutants in the DNA recognition domain of ZEBRA, namely Z(Y180E), Z(R187K) and Z(K188A), were similarly deficient at activating lytic DNA replication and expression of late gene expression but were competent to activate transcription of viral early lytic genes. These mutants all exhibited reduced capacity to interact with DNA as assessed by EMSA, ChIP and an in vivo biotinylated DNA pull-down assay. Over-expression of three virally encoded replication proteins, namely the primase (BSLF1), the single-stranded DNA-binding protein (BALF2) and the DNA polymerase processivity factor (BMRF1), partially rescued the replication defect in these mutants and enhanced ZEBRA's interaction with oriLyt. The findings demonstrate a functional role of replication proteins in stabilizing the association of ZEBRA with viral DNA. Enhanced binding of ZEBRA to oriLyt is crucial for lytic viral DNA replication.
El-Guindy
Ayman
A
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut, USA.
Heston
Lee
L
Miller
George
G
D015152:Blotting, Northern; D015139:Blotting, Southern; D002460:Cell Line; D047369:Chromatin Immunoprecipitation; D004261:DNA Replication / Q000502:physiology*; D024202:Electrophoretic Mobility Shift Assay; D015870:Gene Expression; D015967:Gene Expression Regulation, Viral / Q000502:physiology*; D005814:Genes, Viral; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000378:metabolism*; D014162:Transfection; D014764:Viral Proteins / Q000378:metabolism; D014779:Virus Replication / Q000502:physiology*
C063676:BZLF1 protein, Herpesvirus 4, Human; D015534:Trans-Activators; D014764:Viral Proteins
J Virol. 1996 Nov;70(11):8047-54
8892929
EMBO J. 2000 Jun 15;19(12):3080-9
10856251
Virology. 1997 Mar 31;230(1):22-34
9126259
J Virol. 1995 May;69(5):2998-3006
7707526
J Biol Chem. 2006 Feb 10;281(6):3085-95
16321978
Genes Dev. 2000 Jul 1;14(13):1631-41
10887157
J Biol Chem. 2009 Aug 7;284(32):21557-68
19491105
J Virol. 1992 Aug;66(8):5030-9
1321285
Mol Cell Biol. 1999 Mar;19(3):1617-26
10022850
J Virol. 2002 Nov;76(22):11199-208
12388679
J Virol. 1993 Jul;67(7):4006-16
8389916
J Virol. 2007 Apr;81(7):3303-16
17215287
J Virol. 1990 Mar;64(3):1227-32
2154606
J Virol. 1996 Aug;70(8):5131-42
8764021
J Virol. 2001 Sep;75(18):8792-802
11507224
EMBO J. 1993 Oct;12(10):3921-9
8404860
J Virol. 1992 Aug;66(8):4803-13
1321270
Virology. 2004 Sep 15;327(1):134-43
15327904
Mol Cell Biol. 2001 Jan;21(2):476-87
11134336
J Biol Chem. 1998 Jan 9;273(2):932-9
9422752
Virology. 1996 Jun 15;220(2):367-76
8661388
J Virol. 1990 Mar;64(3):1143-55
2154599
Cell. 1988 Nov 4;55(3):427-33
2846181
J Virol. 1991 May;65(5):2237-44
1850009
Cell. 1986 Dec 26;47(6):883-9
3022942
J Virol. 1996 Mar;70(3):1493-504
8627667
J Virol. 1998 Nov;72(11):8559-67
9765394
J Virol. 1997 Apr;71(4):3054-61
9060666
Nucleic Acids Res. 2005 Jan 26;33(2):536-45
15673714
J Virol. 2004 Nov;78(21):12082-4
15479851
Nat Genet. 2004 Oct;36(10):1099-104
15361873
J Virol. 2006 Sep;80(18):9115-33
16940523
J Virol. 1995 Mar;69(3):1878-86
7853529
J Virol. 1991 Jun;65(6):2868-74
1851858
J Virol. 1999 Aug;73(8):6551-8
10400751
J Virol. 1990 Jun;64(6):2560-8
2159531
J Virol. 2005 Mar;79(6):3409-18
15731235
J Virol. 2005 Jan;79(1):245-56
15596820
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10115-9
8234266
J Virol. 1988 Jul;62(7):2274-84
2836611
J Virol. 1990 Jan;64(1):313-21
2152819
J Virol. 2005 Jun;79(12):7338-48
15919888
EMBO J. 1999 Nov 1;18(21):6095-105
10545120
J Gen Virol. 1996 Mar;77 ( Pt 3):501-9
8601788
J Virol. 2006 Nov;80(22):10942-9
16971443
Mol Cell Biol. 1994 Dec;14(12):8365-75
7969171
J Virol. 2005 Jan;79(2):745-55
15613302
J Virol. 1993 Jul;67(7):4237-45
8389925